Susquehanna International Group’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,246
Closed -$694K 10623
2016
Q3
$694K Buy
+17,246
New +$426K ﹤0.01% 5476
2016
Q2
Sell
-15,734
Closed -$187K 9902
2016
Q1
$187K Buy
+15,734
New +$211K ﹤0.01% 8023
2015
Q3
Sell
-55,978
Closed -$912K 10705
2015
Q2
$912K Buy
+55,978
New +$918K ﹤0.01% 6413

Susquehanna International Group's CYNA Position: Q4 2016 in Review

Susquehanna International Group sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 17,246 shares — an estimated $694K sold.

Susquehanna International Group first reported a position in CYNA in Q2 2015 and held it in 3 quarters. The position peaked at $912K in Q2 2015. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Susquehanna International Group reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Susquehanna International Group sold 17,246 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $694K.
  • Susquehanna International Group first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 3 quarters.
  • Susquehanna International Group's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $912K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.